Innovative Blood-Based Screening for Early Cancer Detection

Oscar Pozo.

Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Spain.

Early detection is essential to improving survival in cancers such as pancreatic, lung and stomach cancer. Yet current diagnostic tools often miss disease at an early stage, leaving patients with limited treatment options and poorer outcomes by the time they are diagnosed. This project aims to develop an innovative blood-based test capable of detecting cancer at its earliest stages and improving outcomes.

The approach will use a minimally invasive blood sample to analyse specific disease-associated signatures. The platform is designed to simplify sample collection and transport while maintaining diagnostic performance. It is also intended to be cost-effective and suitable for large-scale screening programmes, where tests must be accessible, reliable and easy to implement.

The test could allow people with cancer to being treatment sooner, when it is more effective. The test would also improve screening for cancers that are currently difficult to diagnose, potentially improving survival and reducing the need for intensive care and more aggressive procedures.

• Adelaida García, Fundació Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Spain.

STAGE 2